-
Originally Posted by It's2014ComeOnAlready
Someone provide me a better argument why they haven't released results, even to shareholders, in 6+ months and I'll shut up.
Because they don't always release results within months of trial completion. Just a quick sample of previous Allergan trials demonstrates this fact (below). The average from the sample provided is over 15 months. Now Allergan has completed many trials and this was just a sample, but enough to demonstrate they release results at their own leisure. I don't understand all the theories behind something that is not unusual.
Code:
Primary Received Months
Completion Results Apart Identifier
--------------------------------------------------------
5/2012 5/21/2013 12 NCT01391286
1/2011 6/24/2013 29 NCT01189279
2/2014 1/27/2015 11 NCT01698554
5/2014 4/21/2015 11 NCT01830140
10/2011 8/13/2013 22 NCT01291108
4/2013 2/18/2014 10 NCT01646151
12/2013 1/16/2015 13 NCT01863953
11/2010 8/21/2012 21 NCT00907426
9/2010 12/13/2011 15 NCT01068964
7/2010 8/18/2011 13 NCT01064882
-
I thought they were required to release results in a year?
-
"Section 801 of the Food and Drug Administration Amendments Act (FDAAA 801) (PDF) requires Responsible Parties to register and submit summary results of clinical trials with ClinicalTrials.gov. The law applies to certain clinical trials of drugs (including biological products) and medical devices."
https://clinicaltrials.gov/ct2/about-site/results
From my sample above, with exception to three studies, the remaining seven were received at about a year. ClinicalTrials.gov is a government ran site, so I don't know how well this is enforced. What is required and what actually happens are sometimes two different things. For example, look how many people don't file their income tax return. Government doesn't track requirements very well and is generally inefficient.
-
If it worked why waste a year? It needs to pe public the eventual phase 3 anyway, so i don't understand, the complexity of bim and their patent issue are easily fixed by one of the top 5-6 pharma company
-
ok guys i found some info http://ec.europa.eu/competition/merg...4195749_EN.pdf
this document explain the "complexity", very interesting let me know what do you thing about this
-
Originally Posted by Keki
Yea it definitely points to an issue with other companies being able to produce bimatoprost. No way to tell if the trial went well, but it does tell us that the issue with this drug is legally complex.
Just speculating, but if their explanation is that they haven't released results because of these "complexities," then it probably did well. Makes no sense to guard a failure, if overall, there is an issue where other companies can produce the drug themselves. If it didn't work for hair loss, I think we'd know by now. No money to be lost.
-
Has anyone got a definitive answer on when these results will, or have to be released? or are we still shooting in the dark?
-
Originally Posted by FearTheLoss
Has anyone got a definitive answer on when these results will, or have to be released? or are we still shooting in the dark?
Biqqie Smalls is a shareholder, and he contacted investor relations. The person he spoke with said "in a few months," this was last month. So hopefully sometime in August or Sept.
-
Originally Posted by It's2014ComeOnAlready
Biqqie Smalls is a shareholder, and he contacted investor relations. The person he spoke with said "in a few months," this was last month. So hopefully sometime in August or Sept.
I'm with you in believing the results are positive. There is no reason for a company of their size to hold back negative results. I would say 1. the results are great and they are keeping it silent because of patent issues and other companies being able to produce bim. 2. the results are good and they are waiting to see how other trials pan out before spending money on a phase III...either way, it will be interesting to see
-
Allergan is buying Kythera for $2.1 billion. I find this very interesting, given that Kythera's Chief Medical Officer worked at Allergan for over a decade. Also, they announced trials for Setipiprant soon after the phase IIb studies for bimatoprost were complete for Allergan. I'm sure they knew the results, given the company ties. This is very interesting given the mutual reliance on prostaglandin science.
It looks like Allergan may be trying to corner the hair loss market. Look at this quote in April 2014 from Bosley Medical Director, Ken Washenik:
" The true Holy Grail may come from combining a drug like Latisse with a certain type of medication commonly used to treat allergies and asthma. The medication blocks a hormone-like substance that prevents hair from growing. A treatment like this might help with hair growth. Using these drugs in combination is like taking your foot off-break and stepping on gas at the same time."
Looks like Allergan is trying to corner the hair loss market. Sure, nobody wants a double chin either, but if Setipiprant is successful, it would shatter any earnings made by that injectable fat-burning drug. I really hope this means bim was successful, it may mean just that.
Similar Threads
-
By rdawg in forum Cutting Edge / Future Treatments
Replies: 309
Last Post: 12-01-2017, 08:02 AM
-
By Tito555 in forum Hair Loss Treatments
Replies: 7
Last Post: 05-07-2015, 08:58 PM
-
By Desmond84 in forum Cutting Edge / Future Treatments
Replies: 344
Last Post: 02-26-2014, 02:42 AM
-
By matlondon in forum Cutting Edge / Future Treatments
Replies: 110
Last Post: 10-20-2013, 03:14 PM
-
By Scoots in forum Cutting Edge / Future Treatments
Replies: 6
Last Post: 06-20-2012, 06:28 PM
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
Forum Rules
|
» IAHRS
» The Bald Truth
» americanhairloss.org
|
Bookmarks